the neuroscience and pharmacology of addiction 2014 · • acetylcholine-involutary...

27
7/2/14 1 Pharmacology For the Addiction Professional The Neuroscience of Addiction 2014: The Anti-Reward Brain System – Part 1 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D Clinical Associate Professor University of Georgia College of Pharmacy Athens, Georgia [email protected] Merrill Norton Pharm.D.,D.Ph.,ICCDPD 1 The Neuroscience and Pharmacology of Addiction 2014 7/2/14 2 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D Addiction is a Complex Illness …with biological, sociological and psychological components 7/2/14 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Upload: others

Post on 23-May-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

1  

Pharmacology For the Addiction Professional

The Neuroscience of Addiction 2014:

The Anti-Reward Brain System – Part 1

Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D Clinical Associate Professor University of Georgia College of Pharmacy Athens, Georgia [email protected]

Merrill  Norton  Pharm.D.,D.Ph.,ICCDP-­‐D   1  

The Neuroscience and Pharmacology of Addiction 2014

7/2/14 2 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Addiction is a Complex Illness

…with biological, sociological and

psychological components

7/2/14 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Page 2: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

2  

What is Addiction???? !   Changes in neurochemistry

!   Changes in neurohormones

!   Changes in neuropathways

!   Changes in stress response

!   Changes in limbic system

!   Changes in the autonomic systems

!   Changes in pain pathways

!   Changes in perception

The Addicted Brain- 1994-2013

7/2/14 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

DEFINITIONS OF PSYCHOACTIVE CHEMICAL USE, ABUSE, AND

DEPENDENCE ! Psychoactive Chemical Use

!   This term can be applied to a single episode of psychoactive chemical self-administration. Psychoactive chemical use can have adverse consequences that require treatment, and it can lead to psychoactive chemical abuse or dependence, but it may also be self-limiting and have no adverse effects. Psychoactive chemical use has no diagnostic criteria in the DSM-IV.

Page 3: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

3  

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Psychoactive Chemical Use

!   Single episode

!   May have consequences-allergic reactions

!   May lead to abuse , addiction , and dependence

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Endorphins/Dopamine Receptors

USE 1 Cortex

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Psychoactive Chemical Abuse

!   Failure to meet a role obligation

!   Placing yourself or others in physically hazardous situations

!   Legal problems

!   Repeat of the above

!   12 Month Period

!   Estimate 50% Population US meet criteria

DSM IV TR Criteria

Page 4: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

4  

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

ABUSE 2 Midbrain

Physical Dependence

Physical and Psychological Dependence

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Psychoactive Chemical Dependence

!   Tolerance

!   Physical Withdrawal

!   Chemical taken longer/larger amounts than intended

!   Preoccupation

!   Time acquiring,using,recovering from drug

!   Important people,places,things become less important

!   Compulsivity DSM IV TR Criteria

Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D Clinical Associate Professor

University of Georgia College of Pharmacy

Koob,G. LeMoal,M.,Addiction and the Antireward Brain System,Annu. Rev. Psychol. 2008.59:29-53

Page 5: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

5  

}  Drug addiction (substance dependence) is characterized by: ◦  Compulsion to seek and take the drug ◦  Loss of control in limiting intake ◦  Emergence of a negative emotional state when

drug access prevented

Stages of the Addiction Cycle

¨  Usually a single episode ¨  May have consequences depending on

amount of drug taken: ¨  1. Physical - allergic reactions to the drug, similar

to a penicillin like reaction; ¨  2. Emotional – may cause depression or over-

excitation depending on the drug classification; ¨  3. Social/Legal: violence, fights or DUIs

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D 15

Page 6: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

6  

Drug abuse (includes alcohol) is a  patterned  use  of  a  substance  (drug)  in  which  the  user  consumes  the  substance  in  amounts  or  with  methods  neither  approved  nor  supervised  by  medical  professionals.  Substance  abuse/drug  abuse  is  not  limited  to  mood-­‐altering  or  psycho-­‐active  drugs.  If  an  activity  is  performed  using  the  objects  against  the  rules  and  policies  of  the  matter  (as  in  steroids  for  performance  enhancement  in  sports),  it  is  also  called  drug  abuse.  Therefore,  mood-­‐altering  and  psychoactive  substances  are  not  the  only  types  of  drugs  abused.    

¨  There  is  a  wanting  to  use  the  drug  again;  ¨  A  physical  withdrawal  syndrome  may  occur;  ¨  May  have  consequences  similar  to  drug  use  

depending  on  amount  of  drug  taken.  Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 16

+ Desire Corresponds with Drug Use

Liking • Non-problematic Use

Wanting • Abuse

Craving • Addiction

¨  An authoritative definition of drug addiction is that propounded by the World Health Organization: "Drug addiction is a state of periodic and chronic intoxication detrimental to the individual and to society, produced by the repeated consumption of a drug (natural or synthetic). Its characteristics include: (1) An overpowering desire or need (compulsion) to continue taking the drug and to obtain it by any means; (2) A tendency to increase the dose; (3) A psychic (psychological) and sometimes a physical dependence on the effects of the drug.”

Merrill Norton Pharm.D.,D.Ph.,ICCDP-D 18

Page 7: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

7  

Substance Use Disorder - A maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by 2 (or more) of the following, occurring within a 12-month period: 1.recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., repeated absences or poor work performance related to substance use; substance-related absences, suspensions, or expulsions from school; neglect of children or household) 2.recurrent substance use in situations in which it is physically hazardous (e.g., driving an automobile or operating a machine when impaired by substance use)

7/2/14 Georgia Prescription Drug Abuse

Prevention Initiative Training 19

3.continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e.g., arguments with spouse about consequences of intoxication, physical fights) 4.tolerance, as defined by either of the following: a need for markedly increased amounts of the substance to achieve intoxication or desired effect b. markedly diminished effect with continued use of the same amount of the substance (Note: Tolerance is not counted for those taking medications under medical supervision such as analgesics, antidepressants, ant-anxiety medications or beta- blockers.)

7/2/14 Georgia Prescription Drug Abuse

Prevention Initiative Training 20

¨  5. Withdrawal

¨  6. Preoccupation

¨  7. Can’t stay stopped or control use

¨  8 . Spend lots of time obtaining the substance, using the substance, or recovering from its effects;

¨  9. Important social, occupational, or recreational activities are given up or reduced because of substance use;

¨  10. The substance use is continued despite knowing you have a serious physical or psychological problem that is likely to have been caused or emade worse by the substance;

¨  11. Craving or a strong desire or urge to use a specific substance.

7/2/14 Georgia Prescription Drug Abuse

Prevention Initiative Training 21

Page 8: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

8  

+ Cravings

n  Craving: memory of the rewarding aspects of drug use superimposed on a negative emotional state n  Compels drug-seeking in dependent individuals

n  3 Types of Cravings n  Withdrawal induced

n  Drug-induced

n  Cue-induced

+ Cravings

n  Craving: memory of the rewarding aspects of drug use superimposed on a negative emotional state n  Compels drug-seeking in dependent individuals

n  3 Types of Cravings n  Withdrawal induced

n  Drug-induced

n  Cue-induced

7/2/14 24

Drug-induced Craving

High

Craving

Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Page 9: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

9  

DSM 5 Addiction Severity Levels

•  Mild: 2-3 criteria •  Moderate: 4-5 criteria •  Severe: 6 or more

7/2/14 Georgia Prescription Drug Abuse Prevention Initiative Training

25

Biology/genes

Environment

Biology/ Environment Interactions

7/2/14 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Dr.  Merrill  Norton  Pharm.D.,D.Ph.,ICCDP-­‐D  

Factors  Contribu.ng  to  Vulnerability  to  Develop  a  Specific  Addic.on  

use of the drug of abuse essential (100%)!

Genetic (25-50%)"• DNA"• SNPs"• other " polymorphisms"!

Drug-Induced Effects (very high)!

Environmental(very high)"• prenatal"• postnatal"• contemporary"• cues"• comorbidity"

Kreek et al., 2000"

• mRNA levels"• peptides"• proteomics"

• neurochemistry"• behaviors"

Page 10: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

10  

Thinking  Brain  Judgment  Brain  

Instinctual Brain

Pleasure Brain

“I want a beer”

“It  makes  me  feel  goooood”   “Miller Lite”

Nucleus Accumbens

Prefrontal Cortex

Ventral Tegmental Area

Slide used with permission from DVD series “From DisGrace To Grace: The Hijacking of the Brain”

By Dr. Merrill Norton, Pharm.D., D.Ph., ICCDP-D,  University of Georgia, College of Pharmacy

Athens, Georgia

5/21/2013 28 Georgia Prescription Drug Abuse Prevention Initiative Training

Initially, a person takes a drug !hoping to change his or her mood, !

perception, or emotional state!

Translation – !…hoping to change their brains.!

7/2/14" 29"Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D"

}  A concept based on the hypothesis that there are brain systems in place to limit rewards that are triggered by excessive activity in the reward system

Page 11: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

11  

Neurobiology  of  Addic.on  2014  •  AddicCon  is  increasingly  understood  as  a  neurobiological  illness  where  repeCCve  substance  abuse  

corrupts  the  normal  circuitry  of  rewarding  and  adapCve  behaviors  causing  drug-­‐induced  neuroplasCc  changes.    

•  The  addicCve  process  can  be  examined  by  looking  at  the  biological  basis  of  substance  iniCaCon  to  the  progression  of  substance  abuse  to  dependence  to  the  enduring  risk  of  relapse.  

•   CriCcal  neurotransmiPers  and  neurocircuits  underlie  the  pathological  changes  at  each  of  these  stages.    

•  Enhanced  dopamine  transmission  in  the  nucleus  accumbens  is  part  of  the  common  pathway  for  the  posiCvely  rewarding  aspects  of  drugs  of  abuse  and  for  iniCaCon  of  the  addicCve  process.  γ-­‐Aminobutyric  acid,  opioid  pepCdes,  serotonin,  acetylcholine,  the  endocannabinoids,  and  glutamate  systems  also  play  a  role  in  the  iniCal  addicCve  process.    

•  Dopamine  also  plays  a  key  role  in  condiConed  responses  to  drugs  of  abuse,  and  addicCon  is  now  recognized  as  a  disease  of  pathological  learning  and  memory.    

•  In  the  path  from  substance  abuse  to  addic.on,  the  neurochemistry  shiGs  from  a  dopamine-­‐based  behavioral  system  to  a  predominantly  glutamate-­‐based  one  marked  by  dysregulated  glutamate  transmission  from  the  prefrontal  cortex  to  the  nucleus  accumbens  in  rela.on  to  drug  versus  biologically  oriented  s.muli.  This  has  been  called  the  an.-­‐reward  brain.  

•  This  is  a  core  part  of  the  execuCve  dysfuncCon  now  understood  as  one  of  the  hallmark  features  of  addicCon  that  also  includes  impaired  decision  making  and  impulse  dysregulaCon.    

•  Understanding  the  neurobiology  of  the  addicCve  process  allows  for  a  theoreCcal  psychopharmacological  approach  to  treaCng  addicCve  disorders,  one  that  takes  into  account  biological  intervenCons  aimed  at  parCcular  stages  of  the  illness.  

•  The  Neurobiology  of  AddicCve  Disorders  ,Ross,  Stephen  MD;  Peselow,  Eric  MD  

Merrill  Norton  Pharm.D.,D.Ph.,ICCDP-­‐D   31  

}  Moving from impulsive disorder to compulsive disorder, there is a shift from positive reinforcement to negative reinforcement

}  3 stages of cycle of addiction: ◦  Preoccupation/anticipation ◦  Binge/intoxication ◦  Withdrawal/negative affect

We know that despite!their many differences,

most abused substances enhance the dopamine and

serotonin pathways!

7/2/14" 33"Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D"

Page 12: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

12  

Alcohol

Benzodiazepines

Valium

Xanax

Ativan

Non benzodiazepine

Ambien

Sonata

Barbiturates

Fiorinal

Soma

Cocaine

Amphetamine

Methamphetamine

Ephedrine

Ritalin

Ecstasy

Mescaline

DOM

LSD

Psilocibin

DMT

Ibogaine

PCP

Ketamine

Opioids

Opiates

Heroin

Buprenex

Oxycontin

Nicotine

Marijuana

GABA Norepinephrine Serotonin

Cannabinoid- Anandamide

Opiate NMDA Acetylcholine

GHB

7/2/14 34 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

35

“The Necessary Nine” •  Norepinephrine/Epinephrine-

stimulant,anger,fear,anxiety,fight,flight •  Serotonin-depressant,sleep,calm,pleasure •  GABA-relaxant,stress reduction,seizure threshold •  Endorphins-pain relief,pleasure •  Acetylcholine-involutary actions,memory,motivation •  Anandamide-memory,new learning,calmness •  Glutamate-organization of brain signaling,memory,pain •  Dopamine-perception,movement,pleasure •  PIP- loving of one’s self,others,GOD

7/2/14 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

36

Neurotransmitters of Substance Use Disorders

PIP Dopamine Glutamate

Acetylcholine Anandamide

Endorphins / Enkelphins GABA

Serotonin Epinephrine / Norepinephrine

Addiction/Trauma Recovery

Depletion may take less than 12 months

Replenishment may take 5 to 7 years?????

“Human Doing” “Human Being”

7/2/14 Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

Page 13: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

13  

Reward Brain System

Schick Shadel Hospital, 2009 7/2/14 37

Dr. Merrill Norton Pharm.D.,D.Ph.,ICCDP-D

The  An.-­‐Reward  Brain  •  1.  A  key  element  of  addic.on  is  the  

development  of  a  nega.ve  emo.onal  state  during  drug  abs.nence.  

•  2.  The  neurobiological  basis  of  the  nega.ve  emo.onal  state  derives  from  two  sources:  decreased  reward  circuitry  func.on  and  increased  an.-­‐reward  circuitry  func.on.  

•  3.  The  an.-­‐reward  circuitry  func.on  recruited  during  the  addic.on  process  can  be  localized  to  connec.ons  of  the  extended  amygdala  in  the  basal  forebrain.  

•  4.  Neurochemical  elements  in  the  an.reward  system  of  the  extended  amygdala  have  as  a  focal  point  the  extrahypothalamic  cor.cotropin-­‐releasing  factor  system.  

•  5.  Other  neurotransmiSer  systems  implicated  in  the  an.-­‐reward  response  include  norepinephrine,  dynorphin,  neuropep.de  Y,  and  nocicep.n.  

•  6.  Vulnerability  to  addic.on  involves  mul.ple  targets  in  both  the  reward  and  an.-­‐reward  system,  but  a  common  element  is  sensi.za.on  of  brain  stress  systems.  

•  7.  Dysregula.on  of  the  brain  reward  system  and  recruitment  of  the  brain  an.-­‐reward  system  are  hypothesized  to  produce  an  allosta.c  emo.onal  change  that  can  lead  to  pathology.  

•  8.  Nondrug  addic.ons  may  be  hypothesized  to  ac.vate  similar  allosta.c  mechanisms.  

Merrill  Norton  Pharm.D.,D.Ph.,ICCDP-­‐D   38  

Dr.  Merrill  Norton  Pharm.D.,D.Ph.,ICCDP-­‐D   39  

ANTI-­‐REWARD  The  concept  of  an  an.-­‐reward  system  was  developed  to  explain  one  component  of  .me-­‐dependent  neuroadapta.ons  in  response  to  excessive  u.liza.on  of  the  brain  reward  system.    The  brain  reward  system  is  defined  as  ac.va.on  of  circuits  involved  in  posi.ve  reinforcement  with  an  overlay  of  posi.ve  hedonic  valence.    The  neuroadapta.on  simply  could  involve  state-­‐shiGs  on  a  single  axis  of  the  reward  system  (within-­‐  system  change;  dopamine  func.on  decreases).  However,  there  is  compelling  evidence  that  brain  stress/emo.onal  systems  are  recruited  as  a  result  of  excessive  ac.va.on  of  the  reward  system  and  provide  an  addi.onal  source  of  nega.ve  hedonic  valence  that  are  defined  here  as  the  an.-­‐reward  system  (between-­‐system  change;  cor.cotropin-­‐releasing  factor  func.on  increases).  The  combina.on  of  both  a  deficit  in  the    reward  system  (nega.ve  hedonic  valence)  and  recruitment  of  the  brain  stress  systems  (nega.ve  hedonic  valence)  provides  a  powerful  mo.va.onal  state  mediated  in  part  by  the  an.-­‐reward  system.    (Koob  &  Le  Moal  2005).  

7/2/14  

Page 14: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

14  

What is an unconscious emotion?

Unconscious emotion?

Zajonc Öhman Wilson Damasio LeDoux Winkielman

“Our feeling … IS the emotion.” William James What is an emotion? (1894)

“So for emotions, feelings and affects to be unconscious would

be quite out of the question.” Sigmund Freud

The Unconscious (1915)

Analogous to nonconscious blindsight or implicit memory …

What causes hedonic ‘liking’? Brain hedonic hotspots

VTA

Amygdala

Hippocampus

Prefrontal Cortex

Ventral Pallidum

MediodorsalThalamus

Brainstem outputs

After Everitt & Robbins 2005; Nakamura & Kalivas 1999

BL

Ce

core shell

Nucleus Accumbens

Hedonic hotspots: Peciña, Smith, Berridge (2006)

Generating pleasure ‘liking’ via a network of opioid islands

Implications of ‘liking’ vs ‘wanting’? Incentive-Sensitization theory of Addiction Terry Robinson

Neural Sensitization of mesolimbic dopamine systems: Hyper-excitable Caused by amphetamine, cocaine, heroin,

alcohol, nicotine…

Lasts years…

Subjective Pleasure

Time

Rel

ativ

e E

ffect

Incentive Value Initial

Use

Addiction

‘want’

Positive affect

(reward)

‘like’

Page 15: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

15  

Reynolds & Berridge, 2003

Aversive fear (bite, distress, ‘dislike’)

Posterior

Appetitive positive (eat, prefer, ‘like’)

Anterior

Nucleus Accumbens shell Bivalent emotion from corticolimbic tweaks

(Glutamate AMPA blockade by shell DNQX)

Front Back

• Ambivalent middle: +/- both together

• No neutral center

• Positive front , Negative back

+ Desire Corresponds with Drug Use

Liking • Non-problematic Use

Wanting • Abuse

Craving • Addiction

Natural ‘dread reaction’

Fearful defensive treading

(from Donald Owings & Richard Coss) 0

Page 16: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

16  

0

Natural ‘dread reaction’

Fearful defensive treading

(from Donald Owings & Richard Coss)

0 100 200 300 400 500 600 700 800 900

1000 1100

0 1 2 3 4 5  hr Time  After  Amphetamine

%  of

 Bas

al  Relea

se

AMPHETAMINE  

0 50 100 150 200

0 60 120 180 Time  (min)

%  of

 Bas

al  Relea

se

Empty Box Feeding

Di Chiara et al.

FOOD  

VTA/SN nucleus accumbens

frontal cortex

These prescription drugs, like other drugs of abuse (cocaine, heroin, marijuana) raise brain dopamine levels

Dopamine Neurotransmission

Why Do People Abuse Prescription Drugs?

BUT dopamine is also elevated by natural re-enforcers

Merrill Norton D.Ph.,NCAC II,CCS 48

CNS Actions of Corticotropin Releasing Factor (CRF)

Page 17: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

17  

Stages of the Addiction Cycle

Neurobiology of Addiction

Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Binge/Intoxication Stage

Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Page 18: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

18  

Withdrawal/Negative Affect Stage

Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Preoccupation/Anticipation “Craving” Stage

Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Dr.Merrill Norton Pharm.D.,D.Ph.,ICCDP-D 54"

The Nervous System"§  Neural Networks!

§  interconnected neural cells !

§  with experience, networks can learn, as feedback strengthens or inhibits connections that produce certain results !

§  computer simulations of neural networks show analogous learning!

Inputs Outputs

Neurons in the brain connect with one

another to form networks

The brain learns by modifying certain connections in response to feedback

7/2/14"

Page 19: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

19  

CANNABINOIDS

•  Receptors have also been found in the

o  Cerebellum – body movement and coordination

o  Cortex – higher cognitive functions o  Nucleus accumbens – reward o  Basal ganglia – movement control o  Hypothalamus – body temperature,

salt and water balance, reproductive functions

o  Amygdala – emotional responses, fear

55

Positive Reinforcement

Negative Reinforcement

Non-dependent

Negative Reinforcement

Positive Reinforcement

Dependent

Brain Arousal-Stress System Modulation in the Extended Amygdala

From: Koob, G.F. 2008 Neuron 59:11-34

Page 20: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

20  

}  Animals and humans will readily self-administer drugs in the non-dependent state

}  Good correspondence between the ability of drugs to decrease brain reward thresholds and their abuse potential

}  Increased self administration during withdrawal has been observed with cocaine, methamphetamine, nicotine, heroin, and alcohol

}  Rats did not show suppress drug seeking behavior despite aversive condition stimulus or punishment (DSM-IV)

}  Animals have also displayed reinstatement of drug seeking behavior after the behavior has been extinguished ◦  Drug-induced reinstatement ◦  Stress-induced reinstatement

}  Focus of research on the activation of the circuitry related to the origins and terminals of the mesocorticolimbic dopamine system. ◦  Evidence that all major drugs of abuse activate this

system }  Research suggests that multiple parallel

pathways mediate drug reward

Page 21: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

21  

}  Increases in brain reward threshold (decreased reward) occur that highly correlate with the increase in drug intake with extended access

}  It is hypothesized that decreases in reward neurotransmitter function contribute significantly to the negative motivational state during acute withdrawal and may trigger long-term biochemical changes that may explain vulnerability to relapse

}  The hypothalamic-pituitary-adrenal (HPA) axis and the brain stress system are dysregulated by chronic administration of drugs of abuse ◦  Both mediated by corticotropin-releasing factor

(CRF) }  In the case of alcohol withdrawal in rats,

administering CRF receptor antagonists decreased anxiety-like behavior and ethanol self administration ◦  Similar results have been seen with heroin, cocaine,

and nicotine

Page 22: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

22  

Merrill Norton D.Ph.,NCAC II,CCS 64

Merrill Norton D.Ph.,NCAC II,CCS 65

Allostasis - Definition

“The ability to achieve stability through change” “To obtain stability, an organism must vary all of the parameters of its internal milieu and match them appropriately to environmental demands.”

From: Sterling P and Eyer J, Allostasis: a new paradigm to explain arousal pathology. In Fisher S and Reason J (eds), Handbook of Life Stress, Cognition and Health, John Wiley, New York, 1988, pp. 629-647.

}  Dark side may contribute to chronic relapse }  Hypofunctioning and reorganized prefrontal

system drive drug-, cue-, and stress-induced reinstatement neurocircuits, which can cause vulnerability to craving

}  Animal models of craving: ◦  Drug seeking induced by stimuli paired with drug

taking ◦  Drug seeking induced by an acute stressor or state

of stress

Page 23: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

23  

7/2/14 Dr. Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 67

Koob.G 2008

7/2/14 Dr. Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 68

Koob,G 2008

7/2/14 Dr. Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 69

Koob,G 2008

Page 24: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

24  

7/2/14 Dr. Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 70

Koob, G 2008

7/2/14 Dr. Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 71

}  Preadolescent and adolescent exposure to alcohol, tobacco, or drugs of abuse significantly increases the propensity for dependence in adulthood

}  Adolescents first intoxicated with alcohol at age 16 or younger are 2-3 times more likely to develop dependence (similar to tobacco)

}  Early onset of drug use is a predictor of subsequent drug problems

Page 25: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

25  

73

LeDoux, Scientific American, 1994

The Hiker and the Rattlesnake

74

AMYGDALA

Medial Prefrontal Cortex Anterior Cingulate Cortex

Hippocampus

Thalamus

Sights Sounds

Smells Coordinated Response

+

+

+

_

_

Battlemind: Dys-coordination of Threat Response & Dissociation

dissociation

PFC bypass

}  Psychodynamic self-medication hypothesis ◦  Focuses on underlying developmental difficulties,

emotional disturbances, structural factors, building of self, and personality organization ◦  Individuals hypothesized to take drugs as a means

to cope with painful and threatening emotions }  Comorbid Psychiatric disorders ◦  Some of the strongest associations are found with

mood disorders, antisocial personality disorders, and conduct disorders

Page 26: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

26  

7/2/14 Dr. Merrill Norton

Pharm.D.,D.Ph.,ICCDP-D 76

}  There is no single gene for addiction }  Stress, trauma, prenatal stress, and early-

life rearing experiences may alter addiction pathology later in life, via gene expression changes

}  Chronic use of drugs can even lead to DNA modification at particular target genes

}  Allostasis ◦  Defined as stability through change ◦  Involves a feed-forward mechanism rather than

negative feedback mechanisms of homeostasis ◦  Continuous re-evaluation of need and continuous

readjustment of all parameters toward new set points �  Thus, a fine matching of resources to needs

Page 27: The Neuroscience and Pharmacology of Addiction 2014 · • Acetylcholine-involutary actions,memory,motivation • Anandamide-memory,new learning,calmness • Glutamate-organization

7/2/14  

27  

}  Allostatic state ◦  State of chronic deviation of the regulatory system

from its normal (homeostatic) operating level. }  Allostatic Load ◦  Long-term cost of allostasis that accumulates over

time and reflects accumulation of damage that can lead to pathological states

}  The same physiological mechanism that allows rapid response to environmental challenges becomes the engine of pathology if adequate time or resources are not available to shut off the response

}  Two components are hypothesized to adjust to challenges to the brain produced by drugs of abuse ◦  Overactivation of brain reward transmitters and circuits ◦  Recruitment of the brain antireward or brain stress

systems }  Which leads to the compulsivity of drug seeking

and drug taking

}  Impulse control disorders with characteristics similar to drug addiction ◦  Kleptomania ◦  Trichotillomania ◦  Pyromania ◦  Compulsive gambling

}  Other disorders outside of accepted diagnostic disorders ◦  Compulsive shopping, compulsive sexual behavior,

compulsive eating, compulsive exercise, etc.